Gerald W. McLaughlin Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Gerald W. McLaughlin.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Gerald W. McLaughlin. Gerald W. McLaughlin is Director in AYTU BIOPHARMA, INC ($AYTU) and Chief Executive Officer in Neos Therapeutics, Inc. ($NEOS) and Director in Nemus Bioscience, Inc. ($NMUS).

Latest Insider Trading Transactions of Gerald W. McLaughlin

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AYTU, NEOS, NMUS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 12 2021AYTUAYTU BIOPHARMA, IN ...McLaughlin Gerald W.DirectorGrantA0.006,500031,40124.9 K to 31.4 K (+26.10 %)
Mar 19 2021NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...Option ExerciseD2.3165,447151,1830
Mar 19 2021NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...Option ExerciseD5.55100,000555,0000
Mar 19 2021NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...Option ExerciseD1.49395,000588,5500
Mar 19 2021NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...Option ExerciseD2.31392,688907,1090
Mar 19 2021NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...Option ExerciseD6.20600,0003,720,0000
Mar 19 2021NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...SellD0.00270,17100270.2 K to 0 (-100.00 %)
Mar 16 2021NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...Payment of ExerciseF0.8444,32937,414270,171314.5 K to 270.2 K (-14.10 %)
Mar 16 2020NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...Option ExerciseA2.3165,447151,18365,447
Mar 16 2020NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...Option ExerciseA5.55100,000555,000100,000
Mar 04 2020NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...Option ExerciseA1.49395,000588,550395,000
Mar 04 2020NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...GrantA0.00290,0000314,50024.5 K to 314.5 K (+1,183.67 %)
Mar 04 2019NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...Option ExerciseA2.31523,5831,209,477523,583
Dec 10 2018NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...BuyP2.1117,09736,11924,5007.4 K to 24.5 K (+230.95 %)
Dec 07 2018NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...BuyP2.047,40315,1207,4030 to 7.4 K
Jun 28 2018NEOSNeos Therapeutics, ...McLaughlin Gerald W.Chief Executive Off ...Option ExerciseA6.20600,0003,720,000600,000
Oct 22 2015NMUSNemus Bioscience, ...McLaughlin Gerald W.DirectorGrantA0.0030,000061,25031.3 K to 61.3 K (+96.00 %)
Aug 24 2015NMUSNemus Bioscience, ...McLaughlin Gerald W.DirectorOption ExerciseC0.0010,00000
Aug 24 2015NMUSNemus Bioscience, ...McLaughlin Gerald W.DirectorBuyC0.0031,250031,2500 to 31.3 K
Jun 02 2015NMUSNemus Bioscience, ...McLaughlin Gerald W.DirectorOption ExerciseP5.002,00010,0002,000
Jun 02 2015NMUSNemus Bioscience, ...McLaughlin Gerald W.DirectorOption ExerciseP2.5010,00025,00010,000

Page:   1